TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 22450111.
- Also identified by DOI 10.1016/j.athoracsur.2011.11.019.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report transcatheter aortic valve implantation (TAVI) for pure aortic valve insufficiency in a patient with an otherwise normal aortic valve and a long-term left ventricular assist device (LVAD). An oversized 29-mm Edwards SAPIEN valve (Edwards Lifesciences, Irvine, CA) was implanted in the 21-mm native aortic valve annulus. Despite the complete absence of aortic calcifications, the prosthesis remained stably anchored inside the annulus. The reported experience demonstrates that TAVI is feasible even in patients with pure aortic valve regurgitation and can be a reasonable option in patients with aortic regurgitation after LVAD implantation.
Medical subject headings
- Aortic Valve
- Aortic Valve Insufficiency
- Cardiomyopathies
- Heart Valve Prosthesis Implantation
- Heart-Assist Devices